Asian Markets Mixed as Fed Rate Cut Bets Grow and Japan’s Nikkei Leads Gains 
Intel Boosts Malaysia Operations with Additional RM860 Million Investment 
Maduro Confirms “Respectful” Call With Trump, Signals Openness to Diplomatic Dialogue 
U.S.-Russia Talks Leave Ukraine Peace Efforts Uncertain 
Trump Administration Plans Major Rollback of Biden-Era Fuel Economy Standards 
IMF Deputy Dan Katz Visits China as Key Economic Review Nears 
Tech Stocks Lift S&P 500 as Fed Rate-Cut Expectations Rise 
China’s Services Sector Posts Slowest Growth in Five Months as Demand Softens 
Oil Prices Rise as Geopolitical Tensions and Supply Risks Intensify 
Israel Receives Body of Deceased Hostage as Rafah Crossing Reopening Hinges on Final Returns 
Senators Warn Trump Against Unauthorized Venezuela Strike, Vow War Powers Push 
U.S. Soybean Shipments to China Gain Momentum as Trade Tensions Ease 
South Korea Inflation Edges Up in November as Food and Service Costs Climb 
California Launches Portal for Reporting Alleged Misconduct by Federal Immigration Agents 
Oil Prices Rise as Ukraine Targets Russian Energy Infrastructure 
Taiwan Signals Openness to Renew Ties with Honduras as Election Unfolds 
Drones Spotted Near Zelenskiy’s Flight Path in Ireland Trigger Security Alert 
Indonesia is reportedly pushing back against U.S. efforts to introduce so-called “poison pill” clauses into a proposed reciprocal tariff trade agreement, according to a Financial Times report citing individuals familiar with the ongoing negotiations. These clauses are designed to discourage U.S. trading partners from deepening economic ties with China—part of Washington’s broader strategy to counter Beijing’s growing influence across Southeast Asia.
While Reuters has not yet independently verified the report, the development highlights rising geopolitical competition between the United States and China, particularly in regions where both powers seek strategic and economic footholds. For Indonesia, maintaining balanced relationships is crucial. As one of Southeast Asia’s largest economies, Indonesia relies heavily on foreign investment and global trade, including significant economic cooperation with both the U.S. and China.
Washington’s proposed “poison pill” mechanism would reportedly penalize Indonesia if it entered into future trade agreements with China deemed unfavorable by the U.S. The concept mirrors provisions the U.S. previously implemented under the renegotiated NAFTA deal—now known as the USMCA—which included restrictions aimed at curbing members’ trade engagement with non-market economies.
Indonesia’s resistance signals its intent to preserve strategic autonomy. Officials reportedly view such clauses as potentially limiting the country’s economic flexibility and undermining its long-standing goal of maintaining a neutral and diversified foreign policy. Analysts believe Jakarta is cautious about taking steps that could jeopardize its extensive trade relationship with China, which remains one of Indonesia’s top trading partners and a major investor in infrastructure projects.
The negotiations come as the U.S. increasingly works to strengthen economic partnerships in the Indo-Pacific to counter China’s influence. How both sides navigate these disagreements may shape the future of regional trade dynamics and U.S.–Indonesia economic relations.
